{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:35:18Z","timestamp":1793288118273,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000},"content-version":"vor","delay-in-days":142,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07064-2","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:45:07Z","timestamp":1781009107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Childhood burkitt lymphoma: treatment outcomes, survival, and mortality predictors at two tertiary hospitals in Tanzania"],"prefix":"10.1186","volume":"26","author":[{"given":"Haji","family":"Nkya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisa","family":"Shayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Machaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandina T.","family":"Mmbaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kinabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Majaliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"3","key":"7064_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood.2020006926","volume":"137","author":"AM Evens","year":"2021","unstructured":"Evens AM, Danilov A, Jagadeesh D, Sperling A, Kim SH, Vaca R, et al. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers. Blood. 2021;137(3):374\u201386.","journal-title":"Blood"},{"key":"7064_CR2","doi-asserted-by":"publisher","unstructured":"Stefan C, Bray F, Ferlay J, Liu B, Parkin DM. Cancer of childhood in sub-Saharan Africa. Ecancermedicalscience. 2017;11. https:\/\/doi.org\/10.3332\/ecancer.2017.755.","DOI":"10.3332\/ecancer.2017.755"},{"issue":"1","key":"7064_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13244-019-0733-7","volume":"10","author":"K Kalisz","year":"2019","unstructured":"Kalisz K, Alessandrino F, Beck R, Smith D, Kikano E, Ramaiya NH, et al. An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence. Insights Imaging. 2019;10(1):56.","journal-title":"Insights Imaging"},{"issue":"9822","key":"7064_CR4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. Burkitt\u2019s lymphoma. Lancet. 2012;379(9822):1234\u201344.","journal-title":"Lancet"},{"key":"7064_CR5","doi-asserted-by":"publisher","unstructured":"Global, regional, and national epidemiology of childhood Burkitt Lymphoma from 1990 to 2021: statistical analysis of incidence, mortality, and DALYs. https:\/\/doi.org\/10.3389\/fpubh.2025.1560003.","DOI":"10.3389\/fpubh.2025.1560003"},{"key":"7064_CR6","doi-asserted-by":"crossref","unstructured":"NPCR, Incidence \u2013 SEER. U.S. Cancer Statistics Public Use Database Data Standards and Data Dictionary: 2001\u20132015. http:\/\/dx.doi.org\/10.15585\/mmwr.mm6355a4.","DOI":"10.15585\/mmwr.mm6355a4"},{"issue":"1","key":"7064_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13027-019-0236-7","volume":"14","author":"L H\u00e4mmerl","year":"2019","unstructured":"H\u00e4mmerl L, Colombet M, Rochford R, Ogwang DM, Parkin DM. The burden of Burkitt lymphoma in Africa. Infect Agent Cancer. 2019;14(1):17.","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"7064_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","volume":"156","author":"I Magrath","year":"2012","unstructured":"Magrath I. Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol. 2012;156(6):744\u201356.","journal-title":"Br J Haematol"},{"key":"7064_CR9","doi-asserted-by":"crossref","unstructured":"Bouda GC, Traor\u00e9 F, Couitchere L, Raquin MA, Guedenon KM, Pondy A et al. Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d\u2019Oncologie P\u00e9diatrique. J Glob Oncol. 2019;(5):1\u20139.","DOI":"10.1200\/JGO.19.00172"},{"issue":"1","key":"7064_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-9-32","volume":"9","author":"KO Simbiri","year":"2014","unstructured":"Simbiri KO, Biddle J, Kinyera T, Were PA, Tenge C, Kawira E, et al. Burkitt lymphoma research in East Africa: Highlights from the 9thAfrican organization for research and training in cancer conference held in Durban, South Africa in 2013. Infect Agent Cancer. 2014;9(1):1\u20138.","journal-title":"Infect Agent Cancer"},{"key":"7064_CR11","doi-asserted-by":"crossref","unstructured":"Musekwa E, Chapanduka ZC, Bassa F, Kruger M. An 8-year retrospective study of adult and paediatric Burkitt\u2019s lymphoma at Tygerberg Hospital, South Africa. South Afr J Oncol. 2020;4.","DOI":"10.4102\/sajo.v4i0.93"},{"issue":"1","key":"7064_CR12","first-page":"7","volume":"1","author":"A Carbone","year":"2020","unstructured":"Carbone A. Classification of Tumors of the Hematopoietic and Lymphoid Tissues. Discovering Diseases\u2014Defining Their Features Hemato. 2020;1(1):7\u20139.","journal-title":"Discovering Diseases\u2014Defining Their Features Hemato"},{"key":"7064_CR13","unstructured":"Wilson WH, Ph D. Burkitt\u2019s Lymphoma. 2022;1111\u201322."},{"key":"7064_CR14","unstructured":"Wilson WH, Ph D. Burkitt\u2019s Lymphoma. 2022;1111\u201322."},{"key":"7064_CR15","doi-asserted-by":"crossref","unstructured":"Roschewski M, Staudt LM, Wilson WH. Burkitt\u2019s Lymphoma. Longo DL, editor. https:\/\/doi.org\/101056\/NEJMra2025746. 2022;387(12):1111\u201322.","DOI":"10.1056\/NEJMra2025746"},{"issue":"16","key":"7064_CR16","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1182\/bloodadvances.2020002178","volume":"4","author":"NW Ozuah","year":"2020","unstructured":"Ozuah NW, Lubega J, Allen CE, El-Mallawany NK. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa. Blood Adv. 2020;4(16):4007\u201319.","journal-title":"Blood Adv"},{"key":"7064_CR17","doi-asserted-by":"crossref","unstructured":"Ozuah NW, Lubega J, Allen CE, El-mallawany NK. Five decades of low intensity and low survival: adapting intensi fi ed regimens to cure pediatric Burkitt lymphoma in Africa. 2020;4(16):1\u20133.","DOI":"10.1182\/bloodadvances.2020002178"},{"key":"7064_CR18","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1182\/blood-2021-146036","volume":"138","author":"F Manji","year":"2021","unstructured":"Manji F, Chow E, Gerrie A, Chua N, Puckrin R, Stewart D, et al. Outcomes in Relapsed\/Refractory Burkitt Lymphoma: A Multi-Centre Canadian Experience. Blood. 2021;138:2525\u20132525.","journal-title":"Blood"},{"issue":"6","key":"7064_CR19","doi-asserted-by":"publisher","first-page":"E114","DOI":"10.1002\/ajh.24720","volume":"92","author":"NJ Short","year":"2017","unstructured":"Short NJ, Kantarjian HM, Ko H, Khoury JD, Ravandi F, Thomas DA, et al. Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia\/lymphoma. Am J Hematol. 2017;92(6):E114\u20137.","journal-title":"Am J Hematol"},{"issue":"6","key":"7064_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/ijc.30170","volume":"139","author":"G Buckle","year":"2016","unstructured":"Buckle G, Maranda L, Skiles J, Ong\u2019echa JM, Foley J, Epstein M, et al. Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study. Int J Cancer. 2016;139(6):1231\u201340.","journal-title":"Int J Cancer"},{"issue":"4","key":"7064_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1055-9965.EPI-16-0520","volume":"26","author":"AM Noone","year":"2017","unstructured":"Noone AM, Cronin KA, Altekruse SF, Howlader N, Lewis DR, Petkov VI, et al. Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992\u20132013. Cancer Epidemiol Biomarkers Prev. 2017;26(4):632\u201341.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"7064_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/14737140.2019.1606717","volume":"19","author":"L Opanga","year":"2019","unstructured":"Opanga L, Mulaku MN, Opanga SA, Godman B, Kurdi A. Adverse effects of chemotherapy and their management in Pediatric patients with Non-Hodgkin\u2019s Lymphoma in Kenya: A descriptive, situation analysis study. Expert Rev Anticancer Ther. 2019;19(5):423\u201330.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"11","key":"7064_CR23","doi-asserted-by":"publisher","first-page":"e28682","DOI":"10.1002\/pbc.28682","volume":"67","author":"S Srinivasan","year":"2020","unstructured":"Srinivasan S, Roy Moulik N, Kc A, Narula G, Sankaran H, Prasad M, et al. Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in India. Pediatr Blood Cancer. 2020;67(11):e28682.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"7064_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0967772016658785","volume":"27","author":"D Esau","year":"2019","unstructured":"Esau D. Denis Burkitt: A legacy of global health. J Med Biogr. 2019;27(1):4\u20138.","journal-title":"J Med Biogr"},{"issue":"4","key":"7064_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.24953\/turkjped.2021.04.011","volume":"63","author":"S Vural","year":"2021","unstructured":"Vural S, Gen\u00e7 DB, Kebudi R, Do\u011fan \u00d6, Karaman S. Treatment results of modified bfm protocol in pediatric high-risk burkitt lymphoma. Turk J Pediatr. 2021;63(4):639.","journal-title":"Turk J Pediatr"},{"issue":"6Supplement","key":"7064_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1158\/1538-7755.ASGCR23-Abstract-33","volume":"32","author":"H Chapman","year":"2023","unstructured":"Chapman H, Ntemi PS, Kamanga J, Paschal J, Kashaigili HJ, Schroeder K. Abstract 33: Epidemiology, Diagnosis, and Outcomes of Pediatric Burkitt Lymphoma Patients Treated at Bugando Medical Centre in Mwanza, Tanzania. Cancer Epidemiol Biomarkers Prev. 2023;32(6Supplement):33.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"7064_CR27","first-page":"605","volume":"56","author":"M Zhang","year":"2018","unstructured":"Zhang M, Jin L, Yang J, Duan YL, Huang S, Zhou CJ, et al. [Clinical and prognostic analysis of 186 children with Burkitt\u2019s lymphoma]. Zhonghua Er Ke Za Zhi = Chin J Pediatr. 2018;56(8):605\u201310.","journal-title":"Zhonghua Er Ke Za Zhi = Chin J Pediatr"},{"key":"7064_CR28","unstructured":"Couitchere L, Raquin M, anne, Guedenon KM. Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d \u2019 Oncologie P ediatrique original reports abstract. 2023;1\u20139."},{"issue":"5","key":"7064_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/bjh.13986","volume":"173","author":"CC Stanley","year":"2016","unstructured":"Stanley CC, Westmoreland KD, Heimlich BJ, El-Mallawany NK, Wasswa P, Mtete I, et al. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. Br J Haematol. 2016;173(5):705\u201312.","journal-title":"Br J Haematol"},{"issue":"6","key":"7064_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1365-2141.2012.09236.x","volume":"158","author":"T Ngoma","year":"2012","unstructured":"Ngoma T, Adde M, Durosinmi M, Githang\u2019a J, Aken\u2019Ova Y, Kaijage J, et al. Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease. Br J Haematol. 2012;158(6):749\u201362.","journal-title":"Br J Haematol"},{"key":"7064_CR31","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/S2152-2650(20)30866-1","volume":"20","author":"R Khedr","year":"2020","unstructured":"Khedr R, Maged E, Hafez H, Naguib E. ABCL-056: Outcome Predictors of Burkitt\u2019s Lymphoma in Children and Adolescents in Egypt: A Single-Center Study. Clin Lymphoma Myeloma Leuk. 2020;20:S262.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"7064_CR32","first-page":"159","volume":"45","author":"A Su","year":"2018","unstructured":"Su A, Ak A, Bu A, Ibrahim M, Ak A, Bu A. CC \u2013 BY Treatment outcome and abandon- ment rates in a retrospective cohort of children with Burkitt lymphoma in Kano. Nigeria. 2018;45(3):159\u201362.","journal-title":"Nigeria"},{"issue":"6","key":"7064_CR33","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1097\/MPH.0000000000002699","volume":"45","author":"SF Semary","year":"2023","unstructured":"Semary SF, Abdel Rahman H, Elkinaai N, Zaky I, Nagy N, Salem S, et al. Prognostic Factors and Treatment Outcome of Relapsing and Refractory Pediatric Mature B-cell Non-Hodgkin Lymphoma, Children\u2019s Cancer Hospital Egypt Experience. J Pediatr Hematol Oncol. 2023;45(6):e757.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"7064_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3324\/haematol.2014.121434","volume":"100","author":"A Jourdain","year":"2015","unstructured":"Jourdain A, Auperin A, Minard-Colin V, Aladjidi N, Zsiros J, Coze C, et al. Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective Lymphomes Malins B protocols. A Societe Francaise des Cancers de l\u2019Enfant study. Haematologica. 2015;100(6):810\u20137.","journal-title":"Haematologica"},{"issue":"7","key":"7064_CR35","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/ijc.30576","volume":"140","author":"F Mukhtar","year":"2017","unstructured":"Mukhtar F, Boffetta P, Risch HA, Park JY, Bubu OM, Womack L, et al. Survival predictors of Burkitt\u2019s lymphoma in children, adults and elderly in the United States during 2000\u20132013. Int J Cancer. 2017;140(7):1494\u2013502.","journal-title":"Int J Cancer"},{"key":"7064_CR36","doi-asserted-by":"crossref","unstructured":"Aydin B, Akyuz C, Kalkan N, Kurucu N, Varan A, Yalcin B et al. FAB LMB 96 Regimen for Newly Diagnosed Burkitt Lymphoma in Children: Single-center Experience. J Pediatr Hematol Oncol. 2019;41(1).","DOI":"10.1097\/MPH.0000000000001270"},{"issue":"11","key":"7064_CR37","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1080\/10428194.2021.1932873","volume":"62","author":"E Alvarez","year":"2021","unstructured":"Alvarez E, Le T, Kahn J, Winestone L, Li Q, Keegan T. Comorbidities and socioeconomic status are predictors of survival in children and young adults with Burkitt lymphoma. Leuk Lymphoma. 2021;62(11):2804\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"7064_CR38","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/CM9.0000000000001386","volume":"134","author":"S Huang","year":"2021","unstructured":"Huang S, Jin L, Yang J, Duan YL, Zhang M, Zhou CJ, et al. Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab. Chin Med J (Engl). 2021;134(11):1329\u201334.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"7064_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/08880018.2018.1424279","volume":"35","author":"A Patel","year":"2018","unstructured":"Patel A, Sharma MC, Mallick S, Patel M, Bakhshi S. Poor performance status, urban residence and female sex predict inferior survival in pediatric advanced stage mature B-NHL in an Indian tertiary care center. Pediatr Hematol Oncol. 2018;35(1):23\u201332.","journal-title":"Pediatr Hematol Oncol"},{"key":"7064_CR40","doi-asserted-by":"crossref","unstructured":"Woessmann W, Zimmermann M, Meinhardt A, Mueller S, Hauch H, Kn\u00f6rr F et al. Progressive or Relapsed Burkitt Lymphoma or Leukemia in Children and Adolescents after BFM-type First-line Therapy. Blood. 2020;blood.2019003591.","DOI":"10.1182\/blood.2019003591"},{"key":"7064_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-9378-8-36","volume":"8","author":"GC Buckle","year":"2013","unstructured":"Buckle GC, Collins JP, Sumba PO, Nakalema B, Omenah D, Stiffler K, et al. Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional survey. Infect Agent Cancer. 2013;8:36.","journal-title":"Infect Agent Cancer"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07064-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07064-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07064-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:03:41Z","timestamp":1793286221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07064-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7064"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07064-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7810619\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the KCMC University Research Ethics review Commitee (KURERC) (Ref: PG 101\/2023). The requirement for informed consent was waived by the KCMC University Ethics Committee due to the retrospective nature of the study and the use of anonymized secondary data from medical records and oncology registries. Patient confidentiality was maintained throughout the study by anonymizing all extracted data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1082"}}